View All News

USSF’s COVID-19 Oral and Injectable Vaccines Yield Positive Pre-Clinical Results

September 8, 2020

Two promising new COVID-19 vaccines show positive results in pre-clinical trials, developed through an alliance formed by Ben Franklin clients VaxForm LLC, a vaccine development company, and US Specialty Formulations LLC (USSF), a cGMP pharmaceutical manufacturing company. These new vaccines utilize novel delivery platforms for COVID-19 with one oral delivery and the other a conventional injectable. Both vaccine formulations produced antibodies in 100% of mice in pre-clinical trials.

The company alliance was formed in the Ben Franklin TechVentures business/technology incubator, at which both companies are headquartered. Coverage via Lehigh Valley Business

Read More

This entry was posted on Tuesday, September 8th, 2020 at 6:07 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

About the Author

Written by the GamePlanX Network of Experts - https://gameplanx.com, a multidisciplinary team specializing in outcome‑driven strategic growth, regulatory‑compliant digital marketing, and AI‑enabled operational optimization across industries. For this article, the GamePlanX team contributes expertise specifically relevant to USSF’s cGMP pharmaceutical manufacturing operations, botanical injectables, and clinical education initiatives.